منابع مشابه
Evaluation of Intravenous Infusion Systems for Adenosine
Adenosine is used routinely in cardiac perfusion imaging in lieu of exercise stress to enhance coronary blood flow. Since it is a potent drug, intravenous (IV) infusion of adenosine must be carefully controlled to provide optimal pharmacologic effect and minimal adverse effects. There has been particular concern about a sudden increase in adenosine delivery at the time of radiotracer administra...
متن کاملPreparation of Hemoglobin Solutions for Intravenous Infusion
A procedure has been detailed for the preparation of sterile non-pyrogenic solutions of oxyhemoglobin which have the approximate protein content and electrolyte composition of plasma. Large volumes of solution can be rapidly prepared, with 95 to 98 per cent of the hemoglobin in the active form capable of combining with oxygen. The solutions contain no particulate matter; 95 per cent of total bl...
متن کاملHeparin Resistance During and Post-Intravenous Nitroglycerin Infusion
Nitroglycerin has been reported to reduce activated partial thromboplastin time (aPTT) values in patients treated with concurrent heparin and nitroglycerin. However, studies have yielded conflicting results. To determine whether intravenous nitroglycerin alters the anticoagulant effect of heparin, we prospectively evaluated twenty patients admitted for coronary angioplasty by measurin...
متن کامل[Continuous intravenous glucose infusion tests].
Sixty minutes' intravenous glucose infusion tests were carried out in normal subjects, borderline cases, and diabetics which were diagnosed by 50 g oral glucose tolerance test . Infusion was performed at the rate of 5 mg/kg/min . or 15 mg/kg/min. using 5% or 10% glucose. The difference in the insulin responses among thesegroups was rather marked in the case of 15 mg/kg/min. infusion of 10% gluc...
متن کاملA Continuous Subcutaneous Insulin Infusion Needle Break
Our patient was 13 years and 2 months old, a white boy with type 1 diabetes diagnosed 2 years and 5 months before this adverse event (AE). He had no other significant medical history. His A1C was 7.6% 1 month before the insulin infusion needle break event. The patient had started on the t-slim insulin pump (Tandem Diabetes Care, San Diego, Calif.) 1 year and 6 days before the AE occurred. He wa...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: BMJ
سال: 1969
ISSN: 0959-8138,1468-5833
DOI: 10.1136/bmj.1.5636.122